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Although nanoparticulate drug delivery systems (NDDSs) can
preferentially accumulate in tumors, active targeting by targeting
ligands (e.g. monoclonal antibody) is necessary for increasing its
targeting efﬁcacy in vivo. We conjugated mAb198.3 on the
SiO2@AuNP system surface to make it obtain active targeting efﬁ-
cacy. The FAT1 targeting capability of SiO2@AuNP system is the
ﬁrst issue to be solved. Thus, ﬂow cytometry analysis was
attempted to demonstrate that the SiO2@AuNP system could bind
to native FAT1 molecules on the surface of Colo205 cells. Also,
together with the drug release behavior study of self-
decomposable SiO2 NPs, the continuous morphological evolution
needed to be clariﬁed. Therefore, to characterize the morphologi-
cal evolution in vitro, we analyzed the morphology of inner self-
decomposable NPs in different time intervals using transmission
electron microscopy (TEM). A more comprehensive analysis of thisis an open access article under the CC BY license
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G. Wu et al. / Data in Brief 7 (2016) 148–151 149data may be obtained from the article “Multifunctional all-in-one
drug delivery systems for tumor targeting and sequential release of
three different anti-tumor drugs” in Biomaterials.
& 2016 Published by Elsevier Inc. This is an open access article
under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Immunology, Chemistry, Biology
ore speciﬁc sub-
ject areaTargeting and drug releaseype of data Figures
ow data was
acquiredFlow cytometry and transmission electron microscopy analysisata format Normalized data
xperimental
factorsTargeting efﬁcacy and morphology of NP during drug release processxperimental
featuresThe in vitro targeting efﬁciency of the SiO2@AuNP systemwas determined by
ﬂow cytometry analysis in vitro. Also, The degradation of the SiO2 carrier was
monitored by a morphology investigation using TEM.ata source
locationThe Fourth Military Medical University, Xi’an, Shaanxi, Chinaata accessibility The data is with this article and as supporting information to paper pub-
lished in Biomaterials, “Multifunctional all-in-one drug delivery systems for
tumor targeting and sequential release of three different anti-tumor drugs”.Value of the data
 SiO2@AuNP system with high FAT1 targeting efﬁcacy could be developed for multidrug sequential
delivery in colon cancers.
 The approach we took to analysis of FAT1 targeting efﬁcacy in SiO2@AuNP system using FACS could
be useful to others.
 The continuous morphological evolution behavior of the inner self-decomposable SiO2 NPs
monitored by TEM could be useful to others as providing another evidence of drug release.1. Data, experimental design, materials and methods
FAT1 targeting efﬁcacy of SiO2@AuNP system was evaluated using FACS assay. The continuous
morphological evolution behavior of the inner self-decomposable SiO2 NPs was monitored by TEM.
After demonstrating the targeting capability of free mAb198.3_Cy5 and Au-PEG-(Cy5)_mAb198.3
in our previous paper [1], we further double attached mAb198.3 and siRNA onto AuNP system. The
obtained Au-PEG-198.3/siRNA NP was then absorbed on the surface of self-decomposable NP by
electrostatic force. The in vitro targeting efﬁciency against FAT1 molecules of the SiO2@AuNP system
was determined by ﬂow cytometry analysis in vitro.
Reaction of the SiO2@AuNP with Colo205 cells was analyzed using ﬂow cytometry. Colo 205 cells
were harvested and incubated with SiO2@AuNP (40 μg/ml) for 30 min at 4 °C. After incubation, cells
were washed for three times and resuspended in PBS. Samples were analyzed using a FACS Calibur
ﬂow cytometer and CellQuest™ Pro software (BD Bioscience, San Jose, CA). Each experiment was
done in triplicate.
Fig. 1. Flow cytometry analysis investigated the binding capability of SiO2@AuNP system to native FAT1 molecules on the
surface of Colo205 cells.
Fig. 2. TEM images of NPs after being immersed in deionized water at 37 °C for different time intervals.
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molecules on the surface of Colo205 cells (Fig. 1), and this result was consistent with our previous
work on free mAb198.3_Cy5 and Au-PEG-(Cy5) _mAb198.3. This indicated that the SiO2@AuNP sys-
tem has the FAT1 targeting capability (Fig. 1).
After binding to membranes, SiO2@AuNP started its endocytosis process, then endosome/lysosome
escape to cytoplasm. The drug release behavior in the cytoplasm of the SiO2@AuNP system has been
investigated in our submitted paper entitled “Multifunctional all-in-one drug delivery systems for
tumor targeting and sequential release of three different anti-tumor drugs”. Together with the drug
release, the continuous morphological evolution of the inner self-decomposable SiO2 NPs was also
observed using TEM. Equal amounts of SiO2-HCPT/Dox NPs (1 mg/mL) were dispersed in 10 mL
deionized water and centrifuged (10,000 rpm for 5 min) at a different time point. The precipitate of
each sample was re-dispersed in deionized water. Transmission electron microscopy was done to
intuitive study the morphology of particle on a JEOL 7C device at 120 kV. Samples were prepared by
adding a drop (2–3 μL) of re-dispersed NP solution on a copper grid carrying a 20 nm thick carbon
ﬁlm (CF-300-Cu, Electron Microscopy Sciences), and drying for 1 h.
The results showed that most of the NPs remained intact at the ﬁrst 4 h, while rough edges
appeared after 6 h of immersion in deionized water. With the elongation of the immersed hours,
obvious hollow features gradually appeared in the center of the NPs. Such uniform center-hollow
features continued to enlarge over 48 h, leaving a spherical, thin, discontinuous shell (Fig. 2).Acknowledgements
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